About Enhancer

Enhancer ID: E_02_0589
Species: human
Position : chr6:143937411-143939411
Biosample name:
Experiment class : High+Lowthroughput
Enhancer type: Enhancer
Disease: Gestational diabetes mellitus
Pubmed ID:  33171905
Enhancer experiment: Immunohistochemical staining, siRNA knockdown and qPCR, htr-8 / svneo RNA seq
Enhancer experiment description: The most enriched transcription factor, PLAGL1 had a predicted motif in 233 regions that were significantly associated with vasculature development and response to insulin stimulus genes.

About Target gene

Target gene : PLAGL1
Strong evidence: qRT-PCR,qPCR,ChIP,3C
Less strong evidence: RNA-Seq
Target gene experiment description: The most enriched transcription factor, PLAGL1 had a predicted motif in 233 regions that were significantly associated with vasculature development and response to insulin stimulus genes.

About TF

TF name : --
TF experiment: ???????siRNA???qPCR?HTR-8/SVneo RNA-seq
TF experiment description: The most enriched transcription factor, PLAGL1 had a predicted motif in 233 regions that were significantly associated with vasculature development and response to insulin stimulus genes.

About Function

Enhancer function : The most enriched transcription factor, PLAGL1 had a predicted motif in 233 regions that were significantly associated with vasculature development and response to insulin stimulus genes.
Enhancer function experiment: Immunohistochemical staining
Enhancer function
experiment description:
The most enriched transcription factor, PLAGL1 had a predicted motif in 233 regions that were significantly associated with vasculature development and response to insulin stimulus genes.

About SNP

SNP ID: --

Upstream Pathway Annotation of TF

GeneName Pathway Name Source Gene Number

Enhancer associated network

The number on yellow line represents the distance between enhancer and target gene

Expression of target genes for the enhancer


Enhancer associated SNPs